SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,878.00    130.00 (4.73%)
Bid:
2,846.00
Ask:
2,862.00
Spread: 16.00 (0.562%)
Market Cap: £1.59b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

AGM Statement

10 Sep 2013 07:00

RNS Number : 5749N
Oxford Instruments PLC
10 September 2013
 



Oxford Instruments plc

Chairman's AGM Statement 2013

  

Oxford Instruments plc, a leading provider of high technology tools and systems for industry and research, is holding its annual general meeting today in which the Chairman, Nigel Keen will make the following statement:

 

"In June 2011 we outlined our 14 Cubed objective to achieve a compound annual revenue growth rate of 14% and a return on sales of 14% by the financial year ending March 2014. It was anticipated that this objective would be achieved predominantly through organic growth and continuing internal efficiency improvements, augmented by targeted acquisitions.

 

The year to March 2013 was the second year of the 14 Cubed plan and we saw compound revenue growth of 15.6% over the two years with return on sales last year of 14.2%.

 

In the current year, average monthly orders in our Nanotechnology Tools sector are ahead of last year in Asia but are behind in North America and Europe as government agencies in these territories examine their spending on Research and Development. We believe this is particularly true in the USA where the uncertainty caused by budget sequestration has caused orders to be delayed. Asylum Technology, which we acquired in December 2012, is performing well, with results in line with expectations.

 

Our Industrial Products sector has seen growth in average monthly orders over the previous year in Asia and Europe as global economies begin to recover. North America is still down on the prior year but the trend is improving.

 

Our third party service business is performing well with the recently acquired Platinum Medical Imaging business continuing to gain traction and delivering the integration benefits.

  

Outlook

The growth in the order intake rate in Industrial Products and third party Service is encouraging but the slowness in R&D markets in the Western economies means that the year is likely to be more second half weighted than has been seen in recent periods. This will be aided by the continuing recovery in trading conditions in North America

 

 

Enquiries:

 

Oxford Instruments plc Tel: 01865 393200

Jonathan Flint, Chief Executive

Kevin Boyd, Group Finance Director

 

 

MHP Communications Tel: 020 3128 8100

Rachel Hirst / Rory King

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMUKVKROBAKRAR
Date   Source Headline
12th Jun 20269:25 amPRNTransaction in Own Shares
9th Jun 20267:00 amRNSPreliminary Results
1st Jun 20262:03 pmPRNTotal Voting Rights
1st Jun 20261:59 pmPRNIssue of Equity
27th May 20261:58 pmPRNHolding(s) in Company
22nd May 20268:30 amPRNTransaction in Own Shares
14th May 202610:15 amPRNIssue of Equity
8th May 20268:36 amPRNTransaction in Own Shares
1st May 20269:05 amPRNTotal Voting Rights
1st May 20269:00 amPRNTransaction in Own Shares
24th Apr 20268:32 amPRNTransaction in Own Shares
17th Apr 20268:48 amPRNTransaction in Own Shares
14th Apr 202611:07 amPRNHolding(s) in Company
14th Apr 20267:00 amRNSTrading Update
13th Apr 20262:10 pmPRNHolding(s) in Company
13th Apr 20269:15 amPRNHolding(s) in Company
10th Apr 20267:00 amPRNTransaction in Own Shares
7th Apr 202611:11 amPRNTransaction in Own Shares
1st Apr 20263:26 pmPRNHolding(s) in Company
1st Apr 20262:19 pmPRNTotal Voting Rights
30th Mar 20262:54 pmPRNHolding(s) in Company
27th Mar 20268:31 amPRNTransaction in Own Shares
25th Mar 20263:15 pmPRNHolding(s) in Company
20th Mar 20269:00 amPRNTransaction in Own Shares
20th Mar 20268:00 amPRNHolding(s) in Company
17th Mar 202610:00 amPRNHolding(s) in Company
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amPRNTransaction in Own Shares
5th Mar 20262:40 pmPRNHolding(s) in Company
5th Mar 20267:00 amPRNTransaction in Own Shares
4th Mar 20267:00 amPRNTransaction in Own Shares
3rd Mar 20267:00 amPRNTransaction in Own Shares
2nd Mar 202610:38 amPRNTotal Voting Rights
2nd Mar 20267:00 amPRNExtension of Share Buyback Programme
27th Feb 20267:00 amPRNTransaction in Own Shares
26th Feb 20267:00 amPRNTransaction in Own Shares
25th Feb 20267:00 amPRNTransaction in Own Shares
24th Feb 20267:00 amPRNTransaction in Own Shares
23rd Feb 20267:00 amPRNTransaction in Own Shares
20th Feb 20267:00 amPRNTransaction in Own Shares
19th Feb 20267:00 amPRNTransaction in Own Shares
18th Feb 20267:00 amPRNTransaction in Own Shares
17th Feb 20267:00 amPRNTransaction in Own Shares
16th Feb 20267:00 amPRNTransaction in Own Shares
13th Feb 20267:00 amPRNTransaction in Own Shares
12th Feb 20267:00 amPRNTransaction in Own Shares
10th Feb 20267:00 amPRNTransaction in Own Shares
9th Feb 20267:00 amPRNTransaction in Own Shares
6th Feb 20267:00 amPRNTransaction in Own Shares
5th Feb 20267:00 amPRNTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.